신생아 집중 치료용 호흡기 시장 : 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of neonatal intensive care respiratory devices Market

The global neonatal intensive care respiratory devices market was valued at USD 2.05 billion in 2025 and is projected to grow from USD 2.17 billion in 2026 to USD 3.08 billion by 2034, registering a CAGR of 4.47% during the forecast period. North America dominated the global market with a 44.95% market share in 2025, supported by high neonatal intensive care unit (NICU) admissions, increasing prevalence of respiratory distress syndrome (RDS), and rapid adoption of advanced respiratory care technologies.

Neonatal respiratory care devices are essential for treating premature and critically ill newborns suffering from respiratory complications such as respiratory distress syndrome, pneumonia, and other breathing disorders. According to the World Health Organization (WHO), nearly 15 million babies are born prematurely every year, representing around 11% of all births worldwide. Since premature infants often have underdeveloped lungs, the growing number of preterm births continues to increase the demand for advanced respiratory support systems in NICUs across the globe.

Rising Investments and Strategic Collaborations Drive Market Growth

One of the key trends shaping the neonatal intensive care respiratory devices market is the growing focus on research, product innovation, and strategic partnerships among leading manufacturers. Companies are investing heavily in developing technologically advanced ventilators, CPAP systems, oxygen controllers, and respiratory monitoring solutions that improve neonatal outcomes.

Strategic acquisitions have also accelerated market expansion. Companies continue to strengthen their neonatal care portfolios through mergers and product development initiatives, allowing healthcare providers to access more efficient respiratory support technologies. Continuous improvements in neonatal ventilation systems and oxygen delivery devices are expected to enhance treatment quality throughout the forecast period.

Increasing Preterm Births and Respiratory Distress Syndrome Fuel Demand

The primary factor driving market growth is the rising incidence of respiratory distress syndrome among premature infants. RDS remains one of the leading causes of NICU admissions and neonatal mortality worldwide. Premature babies often require immediate respiratory assistance through CPAP systems, ventilators, nasal cannulas, resuscitators, and oxygen therapy devices.

Growing awareness regarding neonatal intensive care and continuous improvements in hospital infrastructure have further increased the adoption of advanced respiratory care equipment. Manufacturers are also focusing on introducing intelligent oxygen management systems that improve patient monitoring while reducing complications associated with oxygen therapy.

Technological innovations such as automated oxygen controllers, advanced ventilators, and extracorporeal membrane oxygenation (ECMO) systems continue to improve respiratory support for newborns, supporting long-term market expansion.

Limited Healthcare Infrastructure Restrains Market Expansion

Despite positive growth prospects, limited adoption of advanced neonatal respiratory care devices in low- and middle-income countries remains a major challenge. Many developing nations continue to face shortages of well-equipped NICUs, trained healthcare professionals, and financial resources required to procure sophisticated respiratory equipment.

In addition, limited awareness regarding neonatal respiratory care guidelines and standardized treatment protocols often results in delayed diagnosis and inadequate respiratory management. These factors continue to restrict market penetration across several emerging healthcare markets.

Devices Segment Leads the Market

Based on product type, the devices segment is expected to dominate the market with a 85.43% share in 2026. Increasing demand for mechanical ventilators, CPAP systems, extracorporeal membrane oxygenation (ECMO), oxygen controllers, and other respiratory support devices is driving segment growth. These products play a vital role in managing respiratory distress syndrome and other pulmonary disorders among premature infants.

The accessories & consumables segment is also expected to witness healthy growth due to increasing usage of nasal cannulas, breathing circuits, resuscitators, nebulizers, and related respiratory accessories during neonatal treatment.

By end-user, the hospitals segment is projected to account for 68.51% of the global market in 2026, supported by rising NICU admissions and growing investments in neonatal intensive care infrastructure. Specialty clinics are also experiencing increasing demand as parents seek advanced respiratory treatment closer to home.

North America Maintains Market Leadership

North America remained the largest regional market, generating USD 0.92 billion in 2025 and is projected to reach USD 0.98 billion in 2026. The region benefits from high NICU admission rates, advanced healthcare infrastructure, favorable reimbursement systems, and continuous product innovation. The U.S. market alone is expected to reach USD 0.91 billion in 2026, supported by strong regulatory approvals and technological advancements.

Europe accounted for USD 0.57 billion in 2025 and is projected to reach USD 0.60 billion in 2026, driven by significant investments in research and neonatal respiratory care technologies. Asia Pacific generated USD 0.37 billion in 2025 and is expected to reach USD 0.39 billion in 2026, recording the fastest growth due to expanding healthcare infrastructure, increasing preterm birth rates, and growing demand for fully equipped NICUs in countries such as China, India, and Japan.

Latin America generated USD 0.11 billion in 2025 and is projected to maintain similar growth in 2026, while the Middle East & Africa continues to witness gradual market expansion supported by improving neonatal healthcare facilities.

Competitive Landscape

The global neonatal intensive care respiratory devices market is moderately consolidated, with leading companies focusing on product innovation, acquisitions, and technological advancements to strengthen their market positions. Major players include Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic, Hamilton Medical, Vyaire Medical, GaleMed Corporation, SLE, and Airon Corporation.

Recent product developments continue to improve neonatal respiratory care. Drager received FDA approval for its Seattle Positive Airway Pressure (PAP) Plus System, while InnAccel introduced the portable neonatal CPAP device SAANS for infants with respiratory distress syndrome. Continuous investments in next-generation respiratory technologies are expected to further strengthen market competition.

Conclusion

The global neonatal intensive care respiratory devices market is expected to witness steady growth through 2034, driven by increasing preterm births, rising cases of neonatal respiratory distress syndrome, expanding NICU infrastructure, and continuous technological advancements in respiratory support systems. Although limited healthcare infrastructure in developing countries remains a challenge, ongoing investments in neonatal healthcare, product innovation, and hospital modernization are expected to create significant growth opportunities. As demand for advanced respiratory care continues to rise worldwide, neonatal respiratory devices will remain essential for improving survival rates and clinical outcomes among premature and critically ill newborns.

ATTRIB UTE DETAILS

Segmentation

By Product Type

• Devices
  • Mechanical Ventilators
  • Bubble CPAP Systems
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Others
• Accessories & Consumables
  • Nasal Prong Cannula
  • Masks
  • Resuscitators
  • Breathing Circuits
  • Others

By End User

• Hospitals
• Specialty Clinics

By Geography

• North America
  • By Product Type
  • By End User
  • By Country
• USA (By Product Type {Devices, and Consumables})
• Canada (By Product Type {Devices, and Consumables})
• Europe
  • By Product Type
  • By End User
  • By Country
• UK (By Product Type {Devices, and Consumables})
• Germany (By Product Type {Devices, and Consumables})
• France (By Product Type {Devices, and Consumables})
• Italy (By Product Type {Devices, and Consumables})
• Spain (By Product Type {Devices, and Consumables})
• Scandinavia (Product Type {Devices, and Consumables})
• Rest of Europe (By Product Type {Devices, and Consumables})
• Asia Pacific
  • By Product Type
  • By End User
  • By Country
• Japan (By Product Type {Devices, and Consumables})
• China (By Product Type {Devices, and Consumables})
• India (By Product Type {Devices, and Consumables})
• Australia (By Product Type {Devices, and Consumables})
• Southeast Asia (By Product Type {Devices, and Consumables})
• Rest of Asia Pacific (By Product Type {Devices, and Consumables})
• Latin America
  • By Product Type
  • By End User
  • By Country
• Brazil (By Product Type {Devices, and Consumables})
• Mexico (By Product Type {Devices, and Consumables})
• Rest of Latin America (By Product Type {Devices, and Consumables})
• The Middle East & Africa
  • By Product Type
  • By End User
  • By Country
• GCC (By Product Type {Devices, and Consumables})
• South Africa (By Product Type {Devices, and Consumables})
• Rest of the MEA (By Product Type {Devices, and Consumables})

Table of Content

1. Introduction

• 1.1. Market Scope
• 1.2. Market Segmentation
• 1.3. Market Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of Key Respiratory Conditions in Neonates, Key Countries, 2025
• 4.2. Statistics, NICU Admissions, Key Countries
• 4.3. Recent Developments, Mergers, Acquisitions, New Product Launches, Etc.
• 4.4. Statistics: Number of NICU Beds, Key Countries,
• 4.5. Live Birth Statistics - Key Countries
• 4.6. Overview of Number of Preterm Births - By Key Countries/ Region
• 4.7. Incidences of Respiratory distress syndrome (RDS) in New-born - By Key Countries/Region
• 4.8. Neonatal Mortality Rate - Key Countries
• 4.9. Pricing Analysis of Respiratory Products
• 4.10. Impact of COVID-19 on the Global Market

5. Global Neonatal Respiratory Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product Type
  • 5.2.1. Devices
    • 5.2.1.1. Bubble CPAP Systems
    • 5.2.1.2. Mechanical Ventilators
    • 5.2.1.3. Extracorporeal Membrane Oxygenation (ECMO)
    • 5.2.1.4. Others
  • 5.2.2. Accessories & Consumables
    • 5.2.2.1. Masks
    • 5.2.2.2. Nasal prong Cannula
    • 5.2.2.3. Breathing Circuits
    • 5.2.2.4. Resuscitators
    • 5.2.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals
  • 5.3.2. Specialty Clinics
• 5.4. Market Analysis, Insights and Forecast - By Geography
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Neonatal Respiratory Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Product Type
  • 6.2.1. Devices
    • 6.2.1.1. Bubble CPAP Systems
    • 6.2.1.2. Mechanical Ventilators
    • 6.2.1.3. Extracorporeal Membrane Oxygenation (ECMO)
    • 6.2.1.4. Others
  • 6.2.2. Accessories & Consumables
    • 6.2.2.1. Masks
    • 6.2.2.2. Nasal prong Cannula
    • 6.2.2.3. Breathing Circuits
    • 6.2.2.4. Resuscitators
    • 6.2.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By End User
  • 6.3.1. Hospitals
  • 6.3.2. Specialty Clinics
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S. (By Product Type {Devices, and Consumables})
  • 6.4.2. Canada (By Product Type {Devices, and Consumables} )

7. Europe Neonatal Respiratory Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Product Type
  • 7.2.1. Devices
    • 7.2.1.1. Bubble CPAP Systems
    • 7.2.1.2. Mechanical Ventilators
    • 7.2.1.3. Extracorporeal Membrane Oxygenation (ECMO)
    • 7.2.1.4. Others
  • 7.2.2. Accessories & Consumables
    • 7.2.2.1. Masks
    • 7.2.2.2. Nasal prong Cannula
    • 7.2.2.3. Breathing Circuits
    • 7.2.2.4. Resuscitators
    • 7.2.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By End User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.4.1. U.K (By Product Type {Devices, and Consumables})
  • 7.4.2. Germany (By Product Type {Devices, and Consumables})
  • 7.4.3. France (By Product Type {Devices, and Consumables})
  • 7.4.4. Spain (By Product Type {Devices, and Consumables})
  • 7.4.5. Italy (By Product Type {Devices, and Consumables})
  • 7.4.6. Scandinavia (By Product Type {Devices, and Consumables})
  • 7.4.7. Rest of Europe (By Product Type {Devices, and Consumables})

8. Asia Pacific Neonatal Respiratory Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Product Type
  • 8.2.1. Devices
    • 8.2.1.1. Bubble CPAP Systems
    • 8.2.1.2. Mechanical Ventilators
    • 8.2.1.3. Extracorporeal Membrane Oxygenation (ECMO)
    • 8.2.1.4. Others
  • 8.2.2. Accessories & Consumables
    • 8.2.2.1. Masks
    • 8.2.2.2. Nasal prong Cannula
    • 8.2.2.3. Breathing Circuits
    • 8.2.2.4. Resuscitators
    • 8.2.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By End User
  • 8.3.1. Hospitals
  • 8.3.2. Specialty Clinics
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.4.1. Japan (By Product Type {Devices, and Consumables})
  • 8.4.2. China (By Product Type {Devices, and Consumables})
  • 8.4.3. India (By Product Type {Devices, and Consumables})
  • 8.4.4. Australia (By Product Type {Devices, and Consumables})
  • 8.4.5. Southeast Asia (By Product Type {Devices, and Consumables})
  • 8.4.6. Rest of Asia Pacific (By Product Type {Devices, and Consumables})

9. Latin America Neonatal Respiratory Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Product Type
  • 9.2.1. Devices
    • 9.2.1.1. Bubble CPAP Systems
    • 9.2.1.2. Mechanical Ventilators
    • 9.2.1.3. Extracorporeal Membrane Oxygenation (ECMO)
    • 9.2.1.4. Others
  • 9.2.2. Accessories & Consumables
    • 9.2.2.1. Masks
    • 9.2.2.2. Nasal prong Cannula
    • 9.2.2.3. Breathing Circuits
    • 9.2.2.4. Resuscitators
    • 9.2.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By End User
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil (By Product Type {Devices, and Consumables})
  • 9.4.2. Mexico (By Product Type {Devices, and Consumables})
  • 9.4.3. Rest of Latin America (By Product Type {Devices, and Consumables})

10. Middle East & Africa Neonatal Respiratory Care Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Product Type
  • 10.2.1. Devices
    • 10.2.1.1. Bubble CPAP Systems
    • 10.2.1.2. Mechanical Ventilators
    • 10.2.1.3. Extracorporeal Membrane Oxygenation (ECMO)
    • 10.2.1.4. Others
  • 10.2.2. Accessories & Consumables
    • 10.2.2.1. Masks
    • 10.2.2.2. Nasal prong Cannula
    • 10.2.2.3. Breathing Circuits
    • 10.2.2.4. Resuscitators
    • 10.2.2.5. Others
• 10.3. Market Analysis, Insights and Forecast - By End User
  • 10.3.1. Hospitals
  • 10.3.2. Specialty Clinics
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. GCC (By Product Type {Devices, and Consumables})
  • 10.4.2. South Africa (By Product Type {Devices, and Consumables})
  • 10.4.3. Rest of Middle East & Africa (By Product Type {Devices, and Consumables})

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Company Profiles
  • 11.3.1. Airon Corporation
    • 11.3.1.1. Overview,
    • 11.3.1.2. Product Types & Services,
    • 11.3.1.3. SWOT Analysis,
    • 11.3.1.4. Recent Developments,
    • 11.3.1.5. Strategies,
    • 11.3.1.6. Financials (Based on Availability)
  • 11.3.2. Dragerwerk AG & Co. KGaA
    • 11.3.2.1. Overview,
    • 11.3.2.2. Product Types & Services,
    • 11.3.2.3. SWOT Analysis,
    • 11.3.2.4. Recent Developments,
    • 11.3.2.5. Strategies,
    • 11.3.2.6. Financials (Based on Availability)
  • 11.3.3. Fisher & Paykel Healthcare Limited
    • 11.3.3.1. Overview,
    • 11.3.3.2. Product Types & Services,
    • 11.3.3.3. SWOT Analysis,
    • 11.3.3.4. Recent Developments,
    • 11.3.3.5. Strategies,
    • 11.3.3.6. Financials (Based on Availability)
  • 11.3.4. GaleMed Corporation
    • 11.3.4.1. Overview,
    • 11.3.4.2. Product Types & Services,
    • 11.3.4.3. SWOT Analysis,
    • 11.3.4.4. Recent Developments,
    • 11.3.4.5. Strategies,
    • 11.3.4.6. Financials (Based on Availability)
  • 11.3.5. GE Healthcare
    • 11.3.5.1. Overview,
    • 11.3.5.2. Product Types & Services,
    • 11.3.5.3. SWOT Analysis,
    • 11.3.5.4. Recent Developments,
    • 11.3.5.5. Strategies,
    • 11.3.5.6. Financials (Based on Availability)
  • 11.3.6. Hamilton Medical
    • 11.3.6.1. Overview,
    • 11.3.6.2. Product Types & Services,
    • 11.3.6.3. SWOT Analysis,
    • 11.3.6.4. Recent Developments,
    • 11.3.6.5. Strategies,
    • 11.3.6.6. Financials (Based on Availability)
  • 11.3.7. Medtronic plc
    • 11.3.7.1. Overview,
    • 11.3.7.2. Product Types & Services,
    • 11.3.7.3. SWOT Analysis,
    • 11.3.7.4. Recent Developments,
    • 11.3.7.5. Strategies,
    • 11.3.7.6. Financials (Based on Availability)
  • 11.3.8. VYAIRE MEDICAL, INC
    • 11.3.8.1. Overview,
    • 11.3.8.2. Product Types & Services,
    • 11.3.8.3. SWOT Analysis,
    • 11.3.8.4. Recent Developments,
    • 11.3.8.5. Strategies,
    • 11.3.8.6. Financials (Based on Availability)
  • 11.3.9. SLE
    • 11.3.9.1. Overview,
    • 11.3.9.2. Product Types & Services,
    • 11.3.9.3. SWOT Analysis,
    • 11.3.9.4. Recent Developments,
    • 11.3.9.5. Strategies,
    • 11.3.9.6. Financials (Based on Availability)
  • 11.3.10. Other Prominent Players
    • 11.3.10.1. Overview,
    • 11.3.10.2. Product Types & Services,
    • 11.3.10.3. SWOT Analysis,
    • 11.3.10.4. Recent Developments,
    • 11.3.10.5. Strategies,
    • 11.3.10.6. Financials (Based on Availability)

12. Strategic Recommendations